Skip to main content
. 2021 May 27;11:11211. doi: 10.1038/s41598-021-90613-9

Figure 1.

Figure 1

Prediction of the homicorcin gene cluster and comparison with other class I lantibiotics. (A) Inhibitory activity of Staphylococcus hominis strain MBL_AB63 (activity overlay assay against Staphylococcus aureus SG511). (B) Biosynthetic gene cluster of different class I lantibiotics. Homicorcin gene cluster was predicted using BAGEL 4.0 (homO: 3-oxoacyl-[acyl-carrier-protein] reductase gene; homI: immunity gene; homA: homicorcin gene; homP: protease gene for leader peptide cleavage; homBC: genes for post translational modification enzyme). (C) Comparisons between the peptide sequences of homicorcin and other class I lantibiotics (residues not similar to Epicidin 280 are shown in red).